Market Exclusive

Analyst Upgrades – Cantel Medical Corp. (NYSE:CMD) Stock Gets Upgraded By Sidoti from Neutral to Buy

Analyst Ratings For Cantel Medical Corp. (NYSE:CMD)

Today, Cantel Medical Corp. (NYSE:CMD) stock received an upgrade by Sidoti from Neutral to Buy with a price target of $92.00.

There are 3 hold ratings, 1 buy rating on the stock.

The current consensus rating on Cantel Medical Corp. (NYSE:CMD) is Hold (Score: 2.25) with a consensus target price of $96.00 per share, a potential 30.42% upside.

Some recent analyst ratings include

Dividend information for Cantel Medical Corp. (NYSE:CMD)

Cantel Medical Corp. (NYSE:CMD) pays an annual dividend of Community Ranking: with a yield of 0.19% and an average dividend growth of 0.00% based on a 3 Year Average.

Dividend History for Cantel Medical Corp. (NYSE:CMD)

Recent Insider Trading Activity For Cantel Medical Corp. (NYSE:CMD)
Cantel Medical Corp. (NYSE:CMD) has insider ownership of 14.90% and institutional ownership of 83.72%.

Recent Trading Activity for Cantel Medical Corp. (NYSE:CMD)
Shares of Cantel Medical Corp. closed the previous trading session at 74.44 up +0.83 1.13% with 79,305 shares trading hands.

Exit mobile version